Product Details
Adcetris 50 mg (Brentuximab vedotin) Injection In Pakistan
Adcetris 50 mg Injection contains brentuximab vedotin, a targeted anticancer medicine known as an antibody–drug conjugate. It targets CD30-positive cells and delivers a cell-killing agent to help treat certain types of lymphoma and other eligible cancers.
It is prescribed by cancer specialists for specific conditions, including Hodgkin lymphoma, systemic anaplastic large cell lymphoma (sALCL), and certain CD30-positive cutaneous T-cell lymphomas, depending on the patient's diagnosis and treatment history.
Key Benefits
-
Targeted Cancer Treatment: Targets cells expressing the CD30 protein.
-
Hodgkin Lymphoma: Used for certain cases of Hodgkin lymphoma, depending on the treatment plan.
-
Lymphoma Management: May be prescribed for systemic anaplastic large cell lymphoma.
-
Selected Skin Lymphomas: Used for eligible cases of CD30-positive cutaneous T-cell lymphoma.
-
Specialist Treatment Option: Can be used alone or alongside other anticancer medicines, depending on the approved indication.
Treatment suitability and outcomes vary according to the cancer type, stage, previous treatment, and the patient's overall health.
Specifications
-
Product Name: Adcetris Injection
-
Strength: 50 mg per vial
-
Active Ingredient: Brentuximab vedotin
-
Medicine Type: Antibody–drug conjugate (targeted anticancer therapy)
-
Dosage Form: Powder for concentrate for solution for infusion
-
Route of Administration: Intravenous infusion only
-
Pack Size: Single-dose 50 mg vial
-
Manufacturer/Marketing Company: Takeda; product arrangements may vary by market
-
Storage: Refrigerate at 2–8°C, do not freeze, and keep in the original carton to protect from light.
How to Use
-
Specialist Prescription: Use only under the supervision of an oncologist experienced in anticancer treatment.
-
Professional Preparation: A trained healthcare professional must reconstitute and dilute the powder using the official product instructions and appropriate sterile technique.
-
Intravenous Infusion: The prepared medicine is administered through a vein in a suitable medical facility.
-
Individualized Dosage: The dose and schedule depend on the cancer being treated, body weight, treatment regimen, and clinical response.
-
Medical Monitoring: Patients require monitoring for infusion reactions, infections, nerve problems, and other adverse effects.
-
Safe Storage: Maintain the required refrigerated storage conditions and protect the vial from light.
